Title:
Prescription and use of a 2-hydroxy 5-phenyl benzoic acid derivative
Document Type and Number:
Japanese Patent JP6067203
Kind Code:
B2
Abstract:
A method of increasing the bioavailability of 5-aminosalicylate compound by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of 5-aminosalicylate compound in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
Inventors:
Lauren johnson
Application Number:
JP2009536219A
Publication Date:
January 25, 2017
Filing Date:
March 23, 2007
Export Citation:
Assignee:
Salix Pharmaceuticals, Inc.
International Classes:
A61K31/606; A61K9/08; A61K9/107; A61K9/20; A61K9/48; A61K31/635; A61P1/04; A61P31/04
Domestic Patent References:
| JP57053449A | ||||
| JP9510958A |
Foreign References:
| WO2000045803A1 | ||||
| WO2005074908A1 |
Other References:
New 薬理学,株式会社 南江堂,1997年 8月 1日,改訂第3版,p.582
Ryde EM and Ahnfelt NO,The pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without food.,Eur J Clin Pharmacol.,1988年,Vol.34 No.5,pp.481-488
Ryde EM and Ahnfelt NO,The pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without food.,Eur J Clin Pharmacol.,1988年,Vol.34 No.5,pp.481-488
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Natsuki Morishita